Table 1.
Frequency in clinical cohorts* | Intellectual disability or developmental delay | Autism spectrum disorder | Schizophrenia | Epilepsy | |
---|---|---|---|---|---|
22q11.2 | 1 in 167 | ✓ | ✓ | ✓ | ✓ |
16p11.2 | 1 in 241 | ✓ | ✓ | ·· | ✓ |
1q21.1 | 1 in 309 | ✓ | ✓ | ✓ | ✓ |
15q13.2-q13.3 | 1 in 358 | ✓ | ✓ | ✓ | ✓ |
7q11.23 | 1 in 415 | ✓ | ✓ | ·· | ✓ |
15q11.2-q13 | 1 in 553 | ✓ | ✓ | ✓ | ✓ |
17q21.31 | 1 in 700 | ✓ | ✓ | ·· | ✓ |
16p13.11 | 1 in 788 | ✓ | ✓ | ✓ | ✓ |
17q12 | 1 in 985 | ✓ | ✓ | ✓ | ✓ |
17p11.2 | 1 in 985 | ✓ | ✓ | ·· | ✓ |
8p23.1 | 1 in 1854 | ✓ | ✓ | ·· | ✓ |
5q35 | 1 in 1970 | ✓ | ✓ | ·· | ✓ |
3q29 | 1 in 2101 | ✓ | ✓ | ✓ | ·· |
Frequency in individuals referred for chromosomal microarray testing. Common indications for testing include neurodevelopmental disorders and multiple congenital anomalies.33